Cell and Gene Therapy CMO and CDMO Facilities

Database of 124 Cell and Gene Therapy CMOs / CDMOs as of 12 July 2019, including 87 companies and 37 academic or government facilities.

This is a global database of facilities that provide (mostly or exclusively) services as contract manufacturing organizations (CMO) and/or contract development and manufacturing organizations (CDMO) for the cell and gene therapy industry worldwide.

Included: Manufacturers of therapeutic cell products (unmodified or gene-modified), iPS cell lines for therapeutic products, viral vectors and DNA plasmids for cell and gene therapy industry.

Excluded: Contract research organizations (CROs) not performing manufacture of the therapeutic product, vendors of supplies (reagents, devices, etc.) 

Update: This list is updated every few months. Since May 2019, a column was added to track Mergers & Acquisitions or name changes for companies in this space.

For each company:

  • Facility name
  • Link to facility website if available
  • Country of origin
  • CMO/CDMO service expertise
  • Mergers & Acquisitions, Notes
  • File has separate lists for CMO/CDMO that are Industry versus Academic/ Government facilities.

 

Public samples: